Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Asthma Drugs Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Quick-relief Medications (Rescue Medications)
  • 1.3.3 Medications for Allergy-induced Asthma
• 1.4 Market Segment by Application
  • 1.4.1 Global Asthma Drugs Market Share by Application (2019-2025)
  • 1.4.2 Allergic Asthma
  • 1.4.3 Non-Allergic Asthma
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Asthma Drugs Market Size
  • 2.1.1 Global Asthma Drugs Revenue 2014-2025
  • 2.1.2 Global Asthma Drugs Sales 2014-2025
• 2.2 Asthma Drugs Growth Rate by Regions
  • 2.2.1 Global Asthma Drugs Sales by Regions 2014-2019
  • 2.2.2 Global Asthma Drugs Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Asthma Drugs Sales by Manufacturers
  • 3.1.1 Asthma Drugs Sales by Manufacturers 2014-2019
  • 3.1.2 Asthma Drugs Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Asthma Drugs Revenue by Manufacturers (2014-2019)
  • 3.2.2 Asthma Drugs Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Asthma Drugs Market Concentration Ratio (CR5 and HHI)
• 3.3 Asthma Drugs Price by Manufacturers
• 3.4 Key Manufacturers Asthma Drugs Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Asthma Drugs Market
• 3.6 Key Manufacturers Asthma Drugs Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Quick-relief Medications (Rescue Medications) Sales and Revenue (2014-2019)
  • 4.1.2 Medications for Allergy-induced Asthma Sales and Revenue (2014-2019)
• 4.2 Global Asthma Drugs Sales Market Share by Type
• 4.3 Global Asthma Drugs Revenue Market Share by Type
• 4.4 Asthma Drugs Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Asthma Drugs Sales by Application

6 United States

• 6.1 United States Asthma Drugs Breakdown Data by Company
• 6.2 United States Asthma Drugs Breakdown Data by Type
• 6.3 United States Asthma Drugs Breakdown Data by Application

7 European Union

• 7.1 European Union Asthma Drugs Breakdown Data by Company
• 7.2 European Union Asthma Drugs Breakdown Data by Type
• 7.3 European Union Asthma Drugs Breakdown Data by Application

8 China

• 8.1 China Asthma Drugs Breakdown Data by Company
• 8.2 China Asthma Drugs Breakdown Data by Type
• 8.3 China Asthma Drugs Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Asthma Drugs Breakdown Data by Company
• 9.2 Rest of World Asthma Drugs Breakdown Data by Type
• 9.3 Rest of World Asthma Drugs Breakdown Data by Application
• 9.4 Rest of World Asthma Drugs Breakdown Data by Countries
  • 9.4.1 Rest of World Asthma Drugs Sales by Countries
  • 9.4.2 Rest of World Asthma Drugs Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer
  • 10.1.1 Pfizer Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.1.4 Asthma Drugs Product Introduction
  • 10.1.5 Pfizer Recent Development
• 10.2 GlaxoSmithKline
  • 10.2.1 GlaxoSmithKline Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.2.4 Asthma Drugs Product Introduction
  • 10.2.5 GlaxoSmithKline Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.3.4 Asthma Drugs Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Merck
  • 10.4.1 Merck Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.4.4 Asthma Drugs Product Introduction
  • 10.4.5 Merck Recent Development
• 10.5 Boehringer Ingelheim
  • 10.5.1 Boehringer Ingelheim Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.5.4 Asthma Drugs Product Introduction
  • 10.5.5 Boehringer Ingelheim Recent Development
• 10.6 AstraZeneca
  • 10.6.1 AstraZeneca Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.6.4 Asthma Drugs Product Introduction
  • 10.6.5 AstraZeneca Recent Development
• 10.7 Roche
  • 10.7.1 Roche Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.7.4 Asthma Drugs Product Introduction
  • 10.7.5 Roche Recent Development
• 10.8 Teva Pharmaceutical
  • 10.8.1 Teva Pharmaceutical Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.8.4 Asthma Drugs Product Introduction
  • 10.8.5 Teva Pharmaceutical Recent Development
• 10.9 Vectura Group
  • 10.9.1 Vectura Group Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Asthma Drugs
  • 10.9.4 Asthma Drugs Product Introduction
  • 10.9.5 Vectura Group Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Asthma Drugs Sales Channels
  • 11.2.2 Asthma Drugs Distributors
• 11.3 Asthma Drugs Customers

12 Market Forecast

• 12.1 Global Asthma Drugs Sales and Revenue Forecast 2019-2025
• 12.2 Global Asthma Drugs Sales Forecast by Type
• 12.3 Global Asthma Drugs Sales Forecast by Application
• 12.4 Asthma Drugs Forecast by Regions
  • 12.4.1 Global Asthma Drugs Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Asthma Drugs Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Asthma is a disease that affects the lungs and is characterized by wheezing, coughing, breathlessness, and chest tightness. It is a chronic ailment of the respiratory tract, which is caused by the obstruction of the flow of air and bronchospasms, where the muscles around the respiratory tract swell up. The disease is believed to be caused by genetic as well as environmental factors.
The American Academy of Allergy Asthma and Immunology classifies asthma under four categories: exercise-induced asthma, allergic asthma, occupational asthma, and childhood asthma. The Asthma and Allergy Foundation of America classifies asthma into two categories: allergic asthma and non-allergic asthma. It is an incurable disease but can be controlled with the help of diagnosis at the right time, followed by regular therapy.
In 2019, the market size of Asthma Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Asthma Drugs.

This report studies the global market size of Asthma Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Asthma Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer
GlaxoSmithKline
Novartis
Merck
Boehringer Ingelheim
AstraZeneca
Roche
Teva Pharmaceutical
Vectura Group

Market Segment by Product Type
Quick-relief Medications (Rescue Medications)
Medications for Allergy-induced Asthma

Market Segment by Application
Allergic Asthma
Non-Allergic Asthma

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Asthma Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Asthma Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Asthma Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025